Patents Assigned to TRANS OVA GENETICS, L.C.
  • Patent number: 12344894
    Abstract: Method for selecting mammalian cells having a genetically-desirable trait, the method comprising culturing an embryo in vitro, dividing the cells from the embryo into aliquots, subjecting the cells from at least one of the aliquots to a genetic analysis, and, based on the results of such analysis, selecting an aliquot of cells. Method for selecting mammalian cells having a genetically-desirable trait, the method comprising culturing an embryo in vitro, transferring the cultured embryo into a recipient female, collecting the embryo, dividing the cells from the embryo into aliquots, subjecting the cells from at least one of the aliquots to a genetic analysis, and, based on the results of such analysis, selecting an aliquot of cells.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: July 1, 2025
    Assignee: TRANS OVA GENETICS, L.C.
    Inventors: Poothappillai K. Kasinathan, Hong Wei, Mark F. Allan, David C. Faber
  • Publication number: 20210189496
    Abstract: Method for selecting mammalian cells having a genetically-desirable trait, the method comprising culturing an embryo in vitro, dividing the cells from the embryo into aliquots, subjecting the cells from at least one of the aliquots to a genetic analysis, and, based on the results of such analysis, selecting an aliquot of cells. Method for selecting mammalian cells having a genetically-desirable trait, the method comprising culturing an embryo in vitro, transferring the cultured embryo into a recipient female, collecting the embryo, dividing the cells from the embryo into aliquots, subjecting the cells from at least one of the aliquots to a genetic analysis, and, based on the results of such analysis, selecting an aliquot of cells.
    Type: Application
    Filed: January 15, 2021
    Publication date: June 24, 2021
    Applicant: TRANS OVA GENETICS, L.C.
    Inventors: Poothappillai K. Kasinathan, Hong Wei, Mark F. Allan, David C. Faber
  • Patent number: 10927411
    Abstract: Genetic tests, such as whole genome analysis (WGA), have been employed to identify genetically superior embryos. The disclosed methods extend in vitro culture time of embryos while awaiting results of genetic tests being performed on a portion of the same embryos. The disclosed methods also help expand the number of cells in each embryo before implantation in the recipient.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: February 23, 2021
    Assignee: TRANS OVA GENETICS, L.C.
    Inventors: Poothappillai K. Kasinathan, Hong Wei, Mark F. Allan, David C. Faber